{"DataElement":{"publicId":"2188522","version":"1","preferredName":"Protocol Version Date","preferredDefinition":"The date of the protocol generation.","longName":"PROT_VER_DT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2013913","version":"1","preferredName":"Protocol Identifier","preferredDefinition":"a means of specifying a protocol for a clinical trial.","longName":"PROT_ID","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2176994","version":"1","preferredName":"Protocol","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.","longName":"Protocol","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AC7-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2184304","version":"1","preferredName":"Identifier","preferredDefinition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"Identifier","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1CDA-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"DWARZEL","dateModified":"2023-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008529","version":"1","preferredName":"Research Protocols","preferredDefinition":"the identification of cancer research protocols.","longName":"RSCH_PROT","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECC2BE-2F27-348A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B203F4CA-46D2-69C7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018550","version":"1","preferredName":"Date","preferredDefinition":"The date on which an observation was made or an event occurred.","longName":"DT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"format":"MM/DD/YYYY","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233081","version":"1","preferredName":"Date","preferredDefinition":"a particular day specified as the time something has, or will, happen.","longName":"C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F90B5E56-BB15-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B54EF112-5457-674A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-28","modifiedBy":"ZHWENDY","dateModified":"2023-12-12","changeDescription":"8/3/17 tt added Diagnosis CSI. 6/20/17 jk transferred to NCI Standards per confirmation by Brian Campbell as part of Round 5 finalization task, added reg status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2179692","version":"1","longName":"TYPE OF CATEGORY","context":"DCP","ClassificationSchemeItems":[{"publicId":"2811734","version":"1","longName":"Case Report Forms","context":"DCP"},{"publicId":"2812325","version":"1","longName":"SeriousAdverseEvents","context":"DCP"},{"publicId":"2957372","version":"1","longName":"Case Report Forms Version 3","context":"DCP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812399","version":"1","longName":"Polyphenon E for Cervical Ca","context":"DCP"},{"publicId":"2812388","version":"1","longName":"Oral Leukoplakia","context":"DCP"},{"publicId":"2812377","version":"1","longName":"Bladder Cancer","context":"DCP"},{"publicId":"2812364","version":"1","longName":"Barretts Esophagus","context":"DCP"},{"publicId":"2812415","version":"1","longName":"Sulindac for Breast Cancer","context":"DCP"},{"publicId":"2812277","version":"1","longName":"Aminolevulinic Acid - Barrett's Esophagus","context":"DCP"},{"publicId":"2812516","version":"1","longName":"Subclinical Neoplastic Lesions","context":"DCP"},{"publicId":"2812102","version":"1","longName":"Budesonide Lung Nodules","context":"DCP"},{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812194","version":"1","longName":"ALA PDT - Oral Leukoplakia","context":"DCP"},{"publicId":"2812177","version":"1","longName":"Safety Study of Resiquimod for Atyical Nevi","context":"DCP"},{"publicId":"2812157","version":"1","longName":"Melanoma Pathobiology - Lovastatin","context":"DCP"},{"publicId":"2812189","version":"1","longName":"Polyphenon E - Pre-prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"2812184","version":"1","longName":"Spectral Markers in ASA","context":"DCP"},{"publicId":"2812174","version":"1","longName":"Polyphenon E - Hormone Receptor-Negative Breast Cancer","context":"DCP"},{"publicId":"2812182","version":"1","longName":"Tissue Effect of Finasteride - Prostate Cancer","context":"DCP"},{"publicId":"2812197","version":"1","longName":"Phase II Resiquimod - Atypical Nevi","context":"DCP"},{"publicId":"2812183","version":"1","longName":"Atrovastatin in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812188","version":"1","longName":"Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men","context":"DCP"},{"publicId":"2812202","version":"1","longName":"DIM - Prostate Cancer","context":"DCP"},{"publicId":"2812190","version":"1","longName":"Acolbifene - High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812155","version":"1","longName":"Sporadic Colorectal Neoplasia - Atrovastatin","context":"DCP"},{"publicId":"2812148","version":"1","longName":"SAMe - Hepatitis C cirrhosis","context":"DCP"},{"publicId":"2812152","version":"1","longName":"Barretts Esophagus - ASA-Esomeprazole","context":"DCP"},{"publicId":"2812154","version":"1","longName":"Bronchial Dysplasia - Sulindac","context":"DCP"},{"publicId":"2812149","version":"1","longName":"Pancreatic Mucinous Neoplasms","context":"DCP"},{"publicId":"2812151","version":"1","longName":"Prostate - Lycopene","context":"DCP"},{"publicId":"2812258","version":"1","longName":"Drug and Carcinogen Enzymes - Resveratrol","context":"DCP"},{"publicId":"2812768","version":"1","longName":"PK and Safety - Novel Retinoid (9cUAB30)","context":"DCP"},{"publicId":"2812551","version":"1","longName":"9cUAB30","context":"DCP"},{"publicId":"2812876","version":"1","longName":"Bronchial Dysplasia - Myo-Inositol","context":"DCP"},{"publicId":"2812539","version":"1","longName":"Polyphenon E - Bladder Cancer","context":"DCP"},{"publicId":"2812553","version":"1","longName":"EGF Receptor Signaling in ACF","context":"DCP"},{"publicId":"2812843","version":"1","longName":"Polyethylene Glycol - Colon Carcinogenesis","context":"DCP"},{"publicId":"2812836","version":"1","longName":"Imiquimod for Atypical Nevi","context":"DCP"},{"publicId":"2812949","version":"1","longName":"Exp. PK Formulations of SR13668","context":"DCP"},{"publicId":"3110219","version":"1","longName":"MSC and L SeMet in Adult Men","context":"DCP"},{"publicId":"2812998","version":"1","longName":"Pioglitazone - Oral Leukoplakia","context":"DCP"},{"publicId":"2813002","version":"1","longName":"Sulindac - Increased Risk of Melanoma","context":"DCP"},{"publicId":"2812736","version":"1","longName":"Transdermal 4-OHT vs oral TAM DCIS of the Breast","context":"DCP"},{"publicId":"2812735","version":"1","longName":"3, 3-Diindolylmethane Cervical Intraepithelial","context":"DCP"},{"publicId":"2813064","version":"1","longName":"Erlotinib - Lesions of Lung","context":"DCP"},{"publicId":"2813043","version":"1","longName":"Ursodeoxycholic Acid - Barrett's Patients","context":"DCP"},{"publicId":"2859628","version":"1","longName":"Breast Sulindac DFMO","context":"DCP"},{"publicId":"2842768","version":"1","longName":"Letrozole - Breast Cancer","context":"DCP"},{"publicId":"2979172","version":"1","longName":"MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia","context":"DCP"},{"publicId":"2936518","version":"1","longName":"Polyphenon E in Women w/ Modulation of Arachidonic Acid","context":"DCP"},{"publicId":"3018781","version":"1","longName":"Metformin Colorectal Cancer","context":"DCP"},{"publicId":"3018782","version":"1","longName":"Resveratrol in Postmenopausal Women","context":"DCP"},{"publicId":"3114163","version":"1","longName":"Cholecalciferol and Genistein","context":"DCP"},{"publicId":"3182879","version":"1","longName":"Metformin - Pre-Prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"3152820","version":"1","longName":"Pioglitazone - Lung Pre-Surgical NSCLC","context":"DCP"},{"publicId":"3182878","version":"1","longName":"Vitamin D - Bioactivity in the Skin","context":"DCP"},{"publicId":"3303133","version":"1","longName":"Pomegranate - Prostate Cancer","context":"DCP"},{"publicId":"3293737","version":"1","longName":"UAB30 in NMSC","context":"DCP"},{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"},{"publicId":"3211792","version":"1","longName":"Barrett's Esophagus Chemoprevention Metformin","context":"DCP"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"DCP"},{"name":"PROT_VER_DT","type":"USED_BY","context":"Theradex"},{"name":"PROT_VER_DT","type":"USED_BY","context":"OHSU Knight"},{"name":"PROT_VER_DT","type":"USED_BY","context":"DCP"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"SUPPDS_QVAL_PROTVDAT","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Protocol Date","type":"Preferred Question Text","description":"Protocol Date","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E49C17FE-4786-0918-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-09-22","modifiedBy":"CLOHNES","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":"6/30/22 Designated CDE to CCTG, added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}